The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
Funder: National Institutes of Health
AGENCY
National Institutes of Health
PROGRAM
Discretionary
AMOUNT
Up to $500K
CLOSES
Mar 5, 2027
Description
This Notice of Funding Opportunity (NOFO) invites new applications to participate in the Diseases of Gastrointestinal Interoception Consortium (DGIC). The overall objectives of this consortium are to: 1) identify the underlying mechanisms that link altered GI interception more directly to GI dysmotility and symptoms; 2) identify disease or response biomarkers that better assess pathophysiology or treatment efficacy; and 3) leverage state-of-the-art technologies to identify novel therapeutic targets that could be assessed in future clinical trials.
This NOFO uses a cooperative agreement mechanism (U01) and runs in parallel with a companion NOFO (RFA-DK-28-214).
Eligibility
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Special district governments; Native American tribal governments (Federally recognized); Independent school districts; Public and State controlled institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); County governments; City or township governments; Private institutions of higher education; Small businesses; Native American tribal organizations (other than Federally recognized tribal governments); For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Contact
Additional details
- Department
- HHS-Nih11
- Funding instrument
- Cooperative Agreement
- Cost sharing required
- No
- Archived
- May 5, 2027
Opportunity number: RFA-DK-28-213
Quote this number when you contact the agency or apply.